ICPT
Intercept Pharmaceuticals Inc
Price:  
19.00 
USD
Volume:  
3,906,757.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ICPT EV/EBITDA

-159.7%
Upside

As of 2024-05-22, the EV/EBITDA ratio of Intercept Pharmaceuticals Inc (ICPT) is -22.57. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ICPT's latest enterprise value is 915.51 mil USD. ICPT's TTM EBITDA according to its financial statements is -40.56 mil USD. Dividing these 2 quantities gives us the above ICPT EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 6.7x - 10.1x 8.8x
Forward P/E multiples 4.2x - 13.2x 8.6x
Fair Price (9.40) - (12.70) (11.34)
Upside -149.5% - -166.8% -159.7%
19.00 USD
Stock Price
(11.34) USD
Fair Price

ICPT EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA